» Articles » PMID: 21544310

Interaction of High-molecular-weight Kininogen with Endothelial Cell Binding Proteins SuPAR, GC1qR and Cytokeratin 1 Determined by Surface Plasmon Resonance (BiaCore)

Overview
Journal Thromb Haemost
Publisher Thieme
Date 2011 May 6
PMID 21544310
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The physiologic activation of the plasma kallikrein-kinin system requires the assembly of its constituents on a cell membrane. High- molecular-weight kininogen (HK) and cleaved HK (HKa) both interact with at least three endothelial cell binding proteins: urokinase plasminogen activator receptor (uPAR), globular C1q receptor (gC1qR,) and cytokeratin 1 (CK1). The affinity of HK and HKa for endothelial cells are KD=7-52 nM. The contribution of each protein is unknown. We examined the direct binding of HK and HKa to the soluble extracellular form of uPAR (suPAR), gC1qR and CK1 using surface plasmon resonance. Each binding protein linked to a CM-5 chip and the association, dissociation and KD (equilibrium constant) were measured. The interaction of HK and HKa with each binding protein was zinc-dependent. The affinity for HK and HKa was gC1qR>CK1>suPAR, indicating that gC1qR is dominant for binding. The affinity for HKa compared to HK was the same for gC1qR, 2.6-fold tighter for CK1 but 53-fold tighter for suPAR. Complex between binding proteins was only observed between gC1qR and CK1 indicating that a binary CK1-gC1qR complex can form independently of kininogen. Although suPAR has the weakest affinity of the three binding proteins, it is the only one that distinguished between HK and HKa. This finding indicates that uPAR may be a key membrane binding protein for differential binding and signalling between the cleaved and uncleaved forms of kininogen. The role of CK1 and gC1qR may be to initially bind HK to the membrane surface before productive cleavage to HKa.

Citing Articles

Diagnostic Accuracy of Novel Protein Biomarkers in Saliva to Detect Periodontitis Using Untargeted 'SWATH' Mass Spectrometry.

Blanco-Pintos T, Regueira-Iglesias A, Relvas M, Alonso-Sampedro M, Bravo S, Balsa-Castro C J Clin Periodontol. 2024; 52(2):199-214.

PMID: 39730307 PMC: 11743018. DOI: 10.1111/jcpe.14103.


Human plasma kallikrein: roles in coagulation, fibrinolysis, inflammation pathways, and beyond.

Motta G, Juliano L, Chagas J Front Physiol. 2023; 14:1188816.

PMID: 37711466 PMC: 10499198. DOI: 10.3389/fphys.2023.1188816.


Tandem Mass Tag (TMT) Quantitative Proteomic Analysis of Serum Exosomes in Cerebral Small-vessel Disease (CSVD) Patients With Depressive Symptoms.

Lu Y, Shen R, Zhu H, Feng Q, Li Y, Xu W Curr Neurovasc Res. 2022; 19(5):449-461.

PMID: 36330621 DOI: 10.2174/1567202620666221103122109.


Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failure.

Giamarellos-Bourboulis E, Poulakou G, de Nooijer A, Milionis H, Metallidis S, Ploumidis M Cell Rep Med. 2022; 3(3):100560.

PMID: 35474750 PMC: 8872836. DOI: 10.1016/j.xcrm.2022.100560.


Baicalin Targets HSP70/90 to Regulate PKR/PI3K/AKT/eNOS Signaling Pathways.

Hou Y, Liang Z, Qi L, Tang C, Liu X, Tang J Molecules. 2022; 27(4).

PMID: 35209223 PMC: 8874410. DOI: 10.3390/molecules27041432.


References
1.
Hasan A, Zisman T, Schmaier A . Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells. Proc Natl Acad Sci U S A. 1998; 95(7):3615-20. PMC: 19884. DOI: 10.1073/pnas.95.7.3615. View

2.
Guo Y, Wang S, Colman R . Kininostatin, an angiogenic inhibitor, inhibits proliferation and induces apoptosis of human endothelial cells. Arterioscler Thromb Vasc Biol. 2001; 21(9):1427-33. DOI: 10.1161/hq0901.095277. View

3.
Shariat-Madar Z, Mahdi F, Schmaier A . Mapping binding domains of kininogens on endothelial cell cytokeratin 1. J Biol Chem. 1999; 274(11):7137-45. DOI: 10.1074/jbc.274.11.7137. View

4.
Keith Jr J, Sainz I, Isordia-Salas I, Pixley R, Leathurby Y, Albert L . A monoclonal antibody against kininogen reduces inflammation in the HLA-B27 transgenic rat. Arthritis Res Ther. 2005; 7(4):R769-76. PMC: 1175023. DOI: 10.1186/ar1728. View

5.
Herwald H, Hasan A, Schmaier A, Muller-Esterl W . Identification of an endothelial cell binding site on kininogen domain D3. J Biol Chem. 1995; 270(24):14634-42. View